Takara Bio Inc. (TYO:4974)
Japan · Delayed Price · Currency is JPY 1,148.00
0.00 (0.00%)
At close: Mar 27, 2026
Takara Bio Market Cap
Takara Bio has a market cap or net worth of 138.24 billion as of March 27, 2026. Its market cap has increased by 36.67% in one year.
Market Cap
138.24B
Enterprise Value
128.68B
Revenue
44.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,148.00
Market Cap Chart
Since December 7, 2004, Takara Bio's market cap has increased from 54.50B to 138.24B, an increase of 153.66%. That is a compound annual growth rate of 4.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 138.24B | 44.40% |
| Dec 30, 2025 | 95.73B | -24.29% |
| Dec 30, 2024 | 126.44B | -16.13% |
| Dec 29, 2023 | 150.76B | -27.34% |
| Dec 30, 2022 | 207.48B | -34.83% |
| Dec 30, 2021 | 318.38B | -4.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 180.93B |
| PeptiDream | 148.73B |
| SanBio Company | 146.70B |
| Nxera Pharma | 81.90B |
| Oncolys BioPharma | 66.86B |
| Cuorips | 58.59B |
| Healios K.K. | 51.03B |
| Stella Pharma | 29.98B |